Biotechnology Companies in Strathcona, Vancouver, BC
Find accurate info on the best businesses belonging to the Biotechnology Companies category in Vancouver. Get reviews and contact details for each business, including phone number, address, opening hours, promotions and other information.
Showing results: 1 - 1 out of 1
Showing results: 1 - 1 out of 1
Results from the 'Biotechnology Companies' category in Strathcona, Vancouver
Closed now
1001 E Pender St, Vancouver, V6A 1W2
(604) 215-8700
Medical equipment supplier, Biotechnology company Nearby results from the Biotechnology Companies category
210-887 Great Northern Way, Vancouver, V5T 4T5
(604) 343-1552
Biotechnology company 
Closed now
887 Great Northern Way, Suite 220, Vancouver, V5T 4T5
(604) 637-3280
Biotechnology company 
Closed now
887 Great Northern Way, suite 220, Vancouver, V5T 4T5
(604) 674-1796
Biotechnology company 
Closed now
Suite 307, 788 Beatty Street, Vancouver, V6B 2M1
Wellness program, Biotechnology company 
Closed now
814 - 470 Granville St, Vancouver, V6C 1V5
Biotechnology company, Packaging company 
Customers express great admiration for Good Natured Products Inc.'s vision and mission to reduce plastic waste through providing convenient, plant-based alternative solutions. The high-quality products are a hit with businesses and individuals alike. Excellent customer service is also highlighted. 
Closed now
2131 Manitoba St, Vancouver, V5Y 0N7
(604) 263-0502
Aspect Biosystems is a Canadian biotechnology company founded in November, 2013. The company spun out from two internationally recognized research groups in engineering and medicine at the University of British Columbia. Aspect Biosystems is working towards a future where doctors determine which drugs work for their patients before prescribing them, where animals are no longer needed for the development of new therapeutics, and where lifesaving transplant organs are created, not harvested. To realise these goals, Aspect has developed a disruptive 3D bioprinting platform technology capable of creating living human tissues on demand. Our initial products aim to improve the predictive accuracy of the pre-clinical drug discovery process by providing the industry and researchers with the technology to create highly customized physiologically-relevant 3D human tissue models that they can employ in the development of new drugs. Aspect’s technology has the potential to drive a fundamental shift in the pharmaceutical industry, enabling the development of completely new therapeutics, and enabling pharma to test drugs they may have shelved in the past due to a lack of appropriate models. Furthermore, Aspect’s technology has the potential to significantly reduce the use of laboratory animals, supporting an industry wide mandate to reduce, refine and replace animal testing. Aspect has a long-term vision to expand beyond applications in drug development, by enabling Human Tissues on Demand™ for broad applications in the life sciences including regenerative medicine and organ transplantation. 
Closed now
789 W Pender St, Suite 810, Vancouver, V6C 1H2
(720) 277-9879
Biotechnology company 
Closed now
570 Granville St #900, Vancouver, V6C 3P1
(604) 248-8730
Biotechnology company 
595 Burrard St, Vancouver, V7X 1L4
(604) 641-4466
irona Biochem was founded in 2009 by its current Chairman and CEO, Dr. Howard Verrico. The Company’s first transaction was to acquire an exclusive global license to TFChem’s proprietary diabetes drug, the SGLT2 Inhibitor. In 2011, Sirona Biochem went on to acquire TFChem’s entire platform and development laboratory in Rouen, France. As a result of the transaction, the founder of TFChem, Dr. Geraldine Deliencourt-Godefroy, became the largest shareholder and Chief Scientific Officer of Sirona Biochem. The value of Sirona and TFChem lies within the proprietary chemistry technology and the team’s expertise. TFChem has developed a fluorination chemistry that can improve the pharmaceutical qualities of carbohydrate-based molecules by stabilizing them. Carbohydrate molecules perform a variety of roles in living organisms and are essential to life. Their importance to life makes them valuable for the development of therapeutics and cosmeceuticals, but while they have broad application potential, they are extremely challenging to develop. Sirona has overcome the challenge of stabilizing carbohydrates to develop safer, more effective cosmetic and pharmaceutical active ingredients. The proprietary chemistry technique developed by TFChem has allowed Sirona to explore the immense commercial opportunities that carbohydrate-based molecules offer. Sirona Biochem’s development focus is centered around three high-valued programs. Each program is selected based on core expertise in the area, market potential, development timeline and high return on investment. 
1066 W Hastings St #2000, DOWNTOWN, Vancouver, V6E 3X2
604-285-6516
Canada Renewable Bioenergy Corp. is focused on producing renewable bio-based products and providing clean energy from biomass wastes through the use of its proprietary, patented pyrolysis technology. Products produced with its pyrolysis technology include electricity, biochar, wood vinegar & creosote.